Online Practice Manuals

Protiva Biotherapeutics Inc. v. Inex Pharmaceuticals Corp.

• 2006 BCSC 1729
  • Go to CanLII for full text
• 2007 BCCA 161
  • Go to CanLII for full text

The above case is referenced within:

1. British Columbia Company Law Practice Manual (Current to: August 15 2023)
   • Chapter 12. Arrangements
     • I. Introduction to Arrangements [§12.1]
       • B. Meaning of Arrangements, Proposals, and Compromises [§12.3]
       • H. When Arrangement Permitted—Judicial Interpretation [§12.14]
     • III. Role of the Court [§12.46]
       • A. Authority of the Court to Make Orders [§12.47]
         • 3. Refusal to Approve: Section 291(4) (a) [§12.50]
       • B. Court Ordered Meetings [§12.51]
         • 2. Nature of Interim Orders [§12.53]
           • a. Preliminary Interim Orders [§12.54]
       • C. Court Approval Order [§12.60]
         • 4. Contents of the Final Order [§12.93]
           • a. Incidental, Consequential, and Supplemental Orders [§12.94]
             • i. Confidentiality and Non-competition Injunctions [§12.95]
             • ii. No-default, Waiver, and Third-party Release Orders [§12.96]
       • D. Transfers of Assets and Liabilities [§12.101]
         • 1. Orders Court May Make [§12.102]
         • 2. Effect of Order on Third Parties [§12.103]
         • 3. Effect of Securities Transfer Act [§12.104]